Accueil > PARTENARIATS > Europe, International


publié le , mis à jour le

Nanoscale insights into Ion Beam Cancer Therapy (Nano-IBCT) COST Action MP1002.
Ion beam therapy offers the possibility of excellent dose localization for treatment of malignant tumours, minimizing radiation damage in normal tissue, while maximizing cell-killing within the tumour.
However, the full potential of such therapy can only be realised by better understanding the physical, chemical and biological mechanisms, on a range of time and space scales, that lead to cell death under ion irradiation.
The proposed Action therefore aims to combine, using a multiscale approach, the unique experimental and theoretical expertise available within Europe to acquire greater insight at the nanoscopic and molecular level into radiation damage induced by ion impact.
Resp. pour le partenaire CIMAP : Bernd A. Huber (CIMAP)

Voir en ligne : NANO-IBCT